RAL is manufactured by Shionogi and is used to treat HIV/AIDS. ## Compulsory licenses Compulsory licenses have been issued for RAL in the following instance: ### Germany issued on August 01, 2016 [[Germany]]'s provisions on compulsory licences can be in Section 24 Patent Act. According to Section 24(1) PatG, it must be demonstrated that: 1. the applicant has tried, within a reasonable period of time, unsuccessfully to obtain permission from the proprietor of the patent to use the invention on reasonable commercial terms and conditions; 2. the public interest calls for the grant of a compulsory licence. In May 2020, the German government passed a “corona crisis package”. The so-called Act for protecting the Population in the Event of an Epidemic Situation of National Importance, (Gesetz zum Schutz der Bevölkerung bei einer epidemischen Lage von nationaler Tragweite) the “Epidemic Protection Act”, provides for several amendments to existing laws. One amendment provides for measures to restrict German patents, e.g. covering pharmaceuticals or medical devices. Find out more at https://www.twobirds.com/en/insights/2020/germany/covid-19-new-german-legislation-to-fight-pandemic-may-affect-granted-patents More information can be found [here](https://e-courses.epo.org/wbts_int/CompulsoryLicensing/CL_DE.pdf). ## Other products issued by the same manufacturer [[RAL]] ## Other products for the same disease [[ARVs]] [[All medicines]] [[EFV]] [[3TC/D4T/NVP]] [[NFV]] [[EFV/FTC/TDF, 3TC/AZT/EFV]] [[RTV]] [[NVP, 3TC, 3TC/AZT]] [[ARVs +]] [[AZT]] [[T-20]] [[DDI, IDV, LPV/r]] [[3TC/AZT/NVP]] [[Dolutegravir]] [[LPV/r]] [[IDV, LPV/r, NVP, TDF]] [[AZT, 3TC, D4T, NVP, 3TC/AZT]] [[NVP, AZT]] [[3TC/AZT]] [[3TC, D4T, AZT, NVP, EFV, TDF, DDI, LPV/r, SQV, RTV, NFV, ABC]] [[ATV]] [[NVP]] [[ABC/3TC]] [[3TC]] [[3TC, NVP, AZT]] [[NVP, 3TC]] [[3TC, 3TC/AZT, 3TC/AZT/NVP, 3TC/D4T, 3TC/D4T/NVP, DDI, EFV, IDV]] [[AZT, 3TC, AZT/3TC, NVP]] [[EFV, NVP, 3TC/AZT]] [[3TC/D4T/NVP, LPV/r]] [[TDF/3TC]] [[AZT, 3TC+AZT]]